A detailed history of Acorn Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Acorn Wealth Advisors, LLC holds 1,746 shares of NVO stock, worth $179,191. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,746
Previous 1,746 -0.0%
Holding current value
$179,191
Previous $249,000 16.87%
% of portfolio
0.09%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $5,644 - $6,757
46 Added 2.71%
1,746 $249,000
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $173,587 - $231,063
1,700 New
1,700 $218,000
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $44,422 - $48,678
-950 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$48.49 - $58.14 $4,849 - $5,814
100 Added 11.76%
950 $45,000
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $40,400 - $45,670
850
850 $46,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Acorn Wealth Advisors, LLC Portfolio

Follow Acorn Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Wealth Advisors, LLC with notifications on news.